Versant Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 27

Professionals

  • Investments
  • 490

  • Portfolio
  • 45

  • Exits
  • 226

Exits

Versant Ventures General Information

Company Description

Founded in 1999, Versant Ventures is a venture capital firm based in San Francisco, California. The firm prefers to invest in companies operating in the biotechnology, manufacturing, life sciences, oncology, industrials, impact investing, and pharmaceuticals sectors. This firm is a Registered Investment Adviser (RIA).

Business Details

Website
versantventures.com
Year Founded
1999
Investor Status
Actively Seeking New Investments
Trade Association
Canadian Venture Capital and Private Equity (CVCPE)
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Corporate Office
  • One Sansome Street
  • Suite 1650
  • San Francisco, CA 94104
  • United States
+1 (415) 000-0000

Versant Ventures Investments (490)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Borealis Biosciences 22-Aug-2024 Early Stage VC 00000 Discovery Tools (Healthcare) Startup 00000 00000
Santa Ana Bio 13-Jun-2024 00000 00000 00000 Drug Discovery Pre-Clinical Trials 000000 00000
Bright Peak Therapeutics 11-Jun-2024 00000 00000 0000 Drug Discovery Pre-Clinical Trials 000000 00000
FireFly Bio 26-Mar-2024 00000 00000 0000 Drug Discovery Generating Revenue 00000 00000
Nouscom 21-Mar-2024 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 00000 00000
Fable Therapeutics 15-Feb-2024 00000 00000 Biotechnology Stealth
Enterprise Therapeutics 26-Jan-2024 00000 00000 000.00 Drug Discovery Generating Revenue 000000000 00
Kolm Therapeutics 01-Jan-2024 00000 00000 Biotechnology Stealth 00000 000000
SixPeaks Bio 01-Jan-2024 Early Stage VC 0000 Drug Discovery Startup 000000000 00
Gate Bioscience 01-Nov-2023 Early Stage VC 0000 Drug Discovery Generating Revenue 00000 00000
You’re viewing 10 of 490 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Versant Ventures Exits (226)

Company Name Exit Date Exit Type Exit Size
Monte Rosa Therapeutics 16-May-2024 Public Investment 2nd Offering 0000
Matterhorn Biosciences 27-Apr-2024 0000000000:
Contineum Therapeutics 05-Apr-2024 000 00000
Q32 Bio 25-Mar-2024 0000000 0000
LENZ Therapeutics 21-Mar-2024 0000000 0000
SanReno Therapeutics 05-Jan-2024 000000000000
RayzeBio 15-Sep-2023 000 00000
Bird Rock Bio 18-Aug-2023 000000000000 000.00
AlterG 11-Aug-2023 Merger/Acquisition 000.00
Chinook Therapeutics 11-Aug-2023 Merger/Acquisition 00.00
You’re viewing 10 of 226 exits. Get the full list »

Versant Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Versant Ventures‘s full profile, request access.

Request a free trial

Versant Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Versant Ventures Management, Team & Partners (77)

Name Title Deals Funds Boards Office
Max Eisenberg JD Chief Operating Officer & General Counsel San Francisco, CA
Charles Warden Co-Founder and Managing Director 00 0 0 San Francisco, CA
Barbara Lubash Co-Founder & Managing Director 00 0 0 San Francisco, CA
Donald Milder Co-Founder & Managing Director 0 0 0 San Francisco, CA
Rebecca Robertson Co-Founder & Managing Director 00 0 0 San Francisco, CA
You’re viewing 5 of 77 team members. Get the full list »

Versant Ventures Co-Investors (166)

Name With Exits Lead Partner Series Industry
RA Capital Management 9 0 00 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
Cormorant Asset Management 0 0 Series chart Industry bar
Casdin Capital 0 0 0 Series chart Industry bar
New Enterprise Associates 0 0 Series chart Industry bar
You’re viewing 5 of 166 co-investors. Get the full list »

Versant Ventures FAQs

  • What is Versant Ventures?

    Founded in 1999, Versant Ventures is a venture capital firm based in San Francisco, California.

  • When was Versant Ventures founded?

    Versant Ventures was founded in 1999.

  • Who is the founder of Versant Ventures?

    Charles Warden, Barbara Lubash, Donald Milder, Rebecca Robertson, Ross Jaffe MD, Samuel Colella, William Link Ph.D, Harold Calvert, and Brian Atwood are the founders of Versant Ventures.

  • Where is Versant Ventures headquartered?

    Versant Ventures is headquartered in San Francisco, CA.

  • What is Versant Ventures's total asset value?

    Versant Ventures has around 00.00 in total assets under management.

  • How many investments has Versant Ventures made?

    Versant Ventures has made 490 investments.

  • What has Versant Ventures invested in?

    Versant Ventures has made numerous investments in companies like Borealis Biosciences, Santa Ana Bio, and Bright Peak Therapeutics within the Discovery Tools (Healthcare) and Drug Discovery industries.

  • What has Versant Ventures invested in recently?

    Versant Ventures's latest investment was on 22-Aug-2024 in Borealis Biosciences, a company within the Discovery Tools (Healthcare) industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »